Flow-through test: Difference between revisions

Revision as of 19:56, 30 September 2012

Revision as of 19:56, 30 September 2012

Line 1:

{{AFC submission|||ts=20120919151135|u=AndreasZH|ns=5}}

'''Flow-through tests''' are a type of diagnostic assay that allows users to test for the presence of a biomarker, usually a specific [[antibody|antibody]], in a sample such as blood. Detection of a specific biomarker aids in the diagnosis of and allows therapeutic action to be initiated quickly. The field of applications for this technology is wide, whereas generally all applications applying [[Lateral_flow_test| lateral flow tests]] can be replaced by flow-through assays. Commercial applications mainly target testing for infectious disease, both by viruses (e.g. [[HIV| HIV]], [[Hepatitis_C| Hepatitis C]], [[Hepatitis_B| Hepatitis B]] <ref name="medmira"> http://www.medmira.com/default.asp?mn=1.21.83.113</ref>

Line 36 ⟶ 33:

==References==

{{reflist}}

<!--- After listing your sources please cite them using inline citations and place them after the information they cite. Please see http://en.wikipedia.org/wiki/Wikipedia:REFB for instructions on how to add citations. --->

*

*